A study comparing miRNA expression in 23 patients with metastatic ccRCC before and after treatment with nivolumab showed a negative association between miR‐22, miR‐24, and soluble PD‐L1 expression.70 This evidence concerns the gene CD274 and nonpapillary renal cell carcinoma.